These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 33747155)

  • 1. miR-130a-3p promotes cell proliferation and invasion by targeting estrogen receptor α and androgen receptor in cervical cancer.
    Fan Q; Huang T; Sun X; Yang X; Wang J; Liu Y; Ni T; Gu S; Li Y; Wang Y
    Exp Ther Med; 2021 May; 21(5):414. PubMed ID: 33747155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-130a regulated by HPV18 E6 promotes proliferation and invasion of cervical cancer cells by targeting TIMP2.
    Yin S; Zhang Q; Wang Y; Li S; Hu R
    Exp Ther Med; 2019 Apr; 17(4):2837-2846. PubMed ID: 30906471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-130a-3p Inhibits PRL Expression and Is Associated With Heat Stress-Induced PRL Reduction.
    Zhang H; Chen T; Xiong J; Hu B; Luo J; Xi Q; Jiang Q; Sun J; Zhang Y
    Front Endocrinol (Lausanne); 2020; 11():92. PubMed ID: 32194503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-3156-3p is downregulated in HPV-positive cervical cancer and performs as a tumor-suppressive miRNA.
    Xia YF; Pei GH; Wang N; Che YC; Yu FS; Yin FF; Liu HX; Luo B; Wang YK
    Virol J; 2017 Feb; 14(1):20. PubMed ID: 28160779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-130a-3p suppresses cell viability, proliferation and invasion in nasopharyngeal carcinoma by inhibiting
    Qu R; Sun Y; Li Y; Hu C; Shi G; Tang Y; Guo D
    Am J Transl Res; 2017; 9(8):3586-3598. PubMed ID: 28861150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-331-3p Suppresses Cervical Cancer Cell Proliferation and E6/E7 Expression by Targeting NRP2.
    Fujii T; Shimada K; Asano A; Tatsumi Y; Yamaguchi N; Yamazaki M; Konishi N
    Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27548144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-130a-3p suppresses cell migration and invasion by inhibition of TBL1XR1-mediated EMT in human gastric carcinoma.
    Wang S; Han H; Hu Y; Yang W; Lv Y; Wang L; Zhang L; Ji J
    Mol Carcinog; 2018 Mar; 57(3):383-392. PubMed ID: 29091326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-130a-3p regulated TGF-β1-induced epithelial-mesenchymal transition depends on SMAD4 in EC-1 cells.
    Tian X; Fei Q; Du M; Zhu H; Ye J; Qian L; Lu Z; Zhang W; Wang Y; Peng F; Chen J; Liu B; Li Q; He X; Yin L
    Cancer Med; 2019 Mar; 8(3):1197-1208. PubMed ID: 30741461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-362-3p Inhibits Migration and Invasion via Targeting BCAP31 in Cervical Cancer.
    Yang S; Zhang X; Sun Y; Shi J; Jiang D; Wang J; Liu Y; Hu C; Pan J; Zheng L; Yang K
    Front Mol Biosci; 2020; 7():107. PubMed ID: 32582765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA RHPN1-AS1 promoted cell proliferation, invasion and migration in cervical cancer via the modulation of miR-299-3p/FGF2 axis.
    Duan H; Li X; Chen Y; Wang Y; Li Z
    Life Sci; 2019 Dec; 239():116856. PubMed ID: 31525429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-130a targeting hypoxia-inducible factor 1 alpha suppresses cell metastasis and Warburg effect of NSCLC cells under hypoxia.
    Shi J; Wang H; Feng W; Huang S; An J; Qiu Y; Wu K
    Life Sci; 2020 Aug; 255():117826. PubMed ID: 32450163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA LINC00667 aggravates the progression of hepatocellular carcinoma by regulating androgen receptor expression as a miRNA-130a-3p sponge.
    Qin Z; Liu X; Li Z; Wang G; Feng Z; Liu Y; Yang H; Tan C; Zhang Z; Li K
    Cell Death Discov; 2021 Dec; 7(1):387. PubMed ID: 34907204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-130a-3p inhibits migration and invasion by regulating RAB5B in human breast cancer stem cell-like cells.
    Kong X; Zhang J; Li J; Shao J; Fang L
    Biochem Biophys Res Commun; 2018 Jun; 501(2):486-493. PubMed ID: 29746865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The microRNA-130a-5p/RUNX2/STK32A network modulates tumor invasive and metastatic potential in non-small cell lung cancer.
    Ma F; Xie Y; Lei Y; Kuang Z; Liu X
    BMC Cancer; 2020 Jun; 20(1):580. PubMed ID: 32571328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential diagnostic and prognostic value and regulatory relationship of long noncoding RNA CCAT1 and miR-130a-3p in clear cell renal cell carcinoma.
    Jing J; Zhao X; Wang J; Li T
    Cancer Cell Int; 2021 Jan; 21(1):68. PubMed ID: 33482824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockdown of lncRNA MFI2-AS1 inhibits lipopolysaccharide-induced osteoarthritis progression by miR-130a-3p/TCF4.
    Luo X; Wang J; Wei X; Wang S; Wang A
    Life Sci; 2020 Jan; 240():117019. PubMed ID: 31678554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver X receptor-α and miR-130a-3p regulate expression of sphingosine 1-phosphate receptor 2 in human umbilical vein endothelial cells.
    Fan A; Wang Q; Yuan Y; Cheng J; Chen L; Guo X; Li Q; Chen B; Huang X; Huang Q
    Am J Physiol Cell Physiol; 2016 Feb; 310(3):C216-26. PubMed ID: 26669941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA CCAT1/miR-130a-3p axis increases cisplatin resistance in non-small-cell lung cancer cell line by targeting SOX4.
    Hu B; Zhang H; Wang Z; Zhang F; Wei H; Li L
    Cancer Biol Ther; 2017 Dec; 18(12):974-983. PubMed ID: 29020498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA H19 interacted with miR-130a-3p and miR-17-5p to modify radio-resistance and chemo-sensitivity of cardiac carcinoma cells.
    Jia J; Zhang X; Zhan D; Li J; Li Z; Li H; Qian J
    Cancer Med; 2019 Apr; 8(4):1604-1618. PubMed ID: 30843379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulation of miR-375/AEG-1 Axis by Human Papillomavirus 16/18-E6/E7 Promotes Cellular Proliferation, Migration, and Invasion in Cervical Cancer.
    Jayamohan S; Kannan M; Moorthy RK; Rajasekaran N; Jung HS; Shin YK; Arockiam AJV
    Front Oncol; 2019; 9():847. PubMed ID: 31552174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.